Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.44
Delayed Data
As of Jul 31
 +0.01 / +0.70%
Today’s Change
0.92
Today|||52-Week Range
2.75
+44.00%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.43
Today’s open1.45
Day’s range-- - --
Volume107,457
Average volume (3 months)121,380
Market cap$72.6M
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)-20.30%
Earnings growth (this year)+9.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+268.74%
P/E ratioNM
Price/Sales4.27
Price/Book33.26

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...-0.00-0.04%
CAPRCapricor Therapeutic...+0.26+5.99%
--United Gene High-Tec...-0.00-1.85%
IMMYImprimis Pharmaceuti...0.000.00%
Data as of 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.3M
Annual profit (last year)-$21.8M
Net profit margin-242.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, Secretary &
Director
Richard W. Pascoe
Chief Accounting Officer &
Vice President-Finance
Catherine Bovenizer
Corporate headquarters
San Diego, California

Forecasts